VESTIGE study

*All characteristics are mean unless otherwise noted. ^bAs the primary imaging endpoint did not reach statistical significance (P>0.05), all subsequent endpoints were reported using nominal p-values. ^cThe statistical significance represents the correlations between 2 parameters.
ACQ, asthma control questionnaire; BD, bronchodilator; CT, computed tomography; EOS, eosinophils; FeNO, fractional exhaled nitric oxide; FEV1, forced expiratory volume in 1 second; FOT, forced oscillation technique FRI, functional residual imaging; ICS, inhaled corticosteroids; ITT, intention-to-treat; iV/Q, image-based ventilation-perfusion ratio; LS, least squares; ppFEV1, percent predicted forced expiratory volume in 1 second; q2w, every 2 weeks.